RxDoctor Payments Data

Sean James, DO

Family Medicine · Corbin, KYNPI 1356729438

Payments from drug & device makers

$4,370in general payments, 2019–2025

Across 268 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$483
  • Lilly USA, LLC$420
  • AstraZeneca$367
  • Vanda Pharmaceuticals Inc.$325
  • GSK$249
  • Novartis$213
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,370100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,370 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$7,672
Medicare patients
60
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban140$162,902
JardianceEmpagliflozin106$120,686
FarxigaDapagliflozin Propanediol53$57,526
OzempicSemaglutide39$54,515
MounjaroTirzepatide40$50,022
JanuviaSitagliptin Phosphate36$48,026
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$44,228
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$20,971
XareltoRivaroxaban28$20,462
MyrbetriqMirabegron16$16,189
EntrestoSacubitril/Valsartan11$15,756
LinzessLinaclotide15$13,323
Fiasp FlextouchInsulin Aspart (Niacinamide)13$10,374
VascepaIcosapent Ethyl17$9,837
Advair HfaFluticasone Propion/Salmeterol18$9,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Prempro$202$165,861153 claims
Boehringer IngelheimJardiance$59$120,686106 claims
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$367$82,75095 claims
Novo NordiskOzempic$212$54,51539 claims
Lilly USA, LLCMounjaro$420$50,02240 claims
MerckJanuvia$116$48,02636 claims
GSKTrelegy Ellipta$249$44,22861 claims
Johnson & JohnsonXarelto, Invokana$43$26,65539 claims
NovartisEntresto$213$15,75611 claims
AbbVieLinzess$483$13,32315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →